AAAAAA

   
Results: 1-17 |
Results: 17
Monitoring minimal residual disease and predicting relapse in APL by quantitating PML-RAR alpha transcripts with a sensitive competitive RT-PCR method
Authors: Tobal, K Moore, H Macheta, M Yin, JAL
Citation: K. Tobal et al., Monitoring minimal residual disease and predicting relapse in APL by quantitating PML-RAR alpha transcripts with a sensitive competitive RT-PCR method, LEUKEMIA, 15(7), 2001, pp. 1060-1065
Recent advances in the treatment of AML
Authors: Macheta, M Yin, JAL
Citation: M. Macheta et Jal. Yin, Recent advances in the treatment of AML, HEMATOL ONC, 19(3), 2001, pp. 107-118
Achieving pregnancy against the odds: successful implantation of frozen-thawed embryos generated by ICSI using spermatozoa banked prior to chemo/radiotherapy for Hodgkin's disease and acute leukaemia
Authors: Horne, G Atkinson, A Brison, DR Radford, J Yin, JAL Edi-Osagie, ECO Pease, EHE Lieberman, BA
Citation: G. Horne et al., Achieving pregnancy against the odds: successful implantation of frozen-thawed embryos generated by ICSI using spermatozoa banked prior to chemo/radiotherapy for Hodgkin's disease and acute leukaemia, HUM REPR, 16(1), 2001, pp. 107-109
Dual colour FISH in paraffin wax embedded bone trephines for identification of numerical and structural chromosomal abnormalities in acute myeloid leukaemia and myelodysplasia
Authors: Le Maitre, CL Byers, RJ Yin, JAL Hoyland, JA Freemont, AJ
Citation: Cl. Le Maitre et al., Dual colour FISH in paraffin wax embedded bone trephines for identification of numerical and structural chromosomal abnormalities in acute myeloid leukaemia and myelodysplasia, J CLIN PATH, 54(9), 2001, pp. 730-733
Central nervous system relapse of acute promyelocytic leukaemia in a patient with cerebral haemorrhage at diagnosis
Authors: Macheta, MP Shun, JK Yin, JAL
Citation: Mp. Macheta et al., Central nervous system relapse of acute promyelocytic leukaemia in a patient with cerebral haemorrhage at diagnosis, BR J HAEM, 114(4), 2001, pp. 954-955
Comparison of 'sequential' versus 'standard' chemotherapy as re-induction treatment, with or without cyclosporine, in refractory/relapsed acute myeloid leukaemia (AML): results of the UK Medical Research Council AML-R trial
Authors: Yin, JAL Wheatley, K Rees, JKH Burnett, AK
Citation: Jal. Yin et al., Comparison of 'sequential' versus 'standard' chemotherapy as re-induction treatment, with or without cyclosporine, in refractory/relapsed acute myeloid leukaemia (AML): results of the UK Medical Research Council AML-R trial, BR J HAEM, 113(3), 2001, pp. 713-726
Stimulation of autologous proliferative and cytotoxic T-cell responses by "leukemic dendritic cells" derived from blast cells in acute myeloid leukemia
Authors: Harrison, BD Adams, JA Briggs, M Brereton, ML Yin, JAL
Citation: Bd. Harrison et al., Stimulation of autologous proliferative and cytotoxic T-cell responses by "leukemic dendritic cells" derived from blast cells in acute myeloid leukemia, BLOOD, 97(9), 2001, pp. 2764-2771
The bone marrow in hereditary cystinosis
Authors: Busuttil, DP Yin, JAL
Citation: Dp. Busuttil et Jal. Yin, The bone marrow in hereditary cystinosis, BR J HAEM, 111(2), 2000, pp. 385-385
Megakaryopoiesis in vitro in myelodysplastic syndromes and acute myeloid leukaemia: effect of pegylated recombinant human megakaryocyte growth and development factor in combination with other growth factors
Authors: Yin, JAL Adams, JA Brereton, ML Hann, A Harrison, BD Briggs, M
Citation: Jal. Yin et al., Megakaryopoiesis in vitro in myelodysplastic syndromes and acute myeloid leukaemia: effect of pegylated recombinant human megakaryocyte growth and development factor in combination with other growth factors, BR J HAEM, 108(4), 2000, pp. 743-746
P-glycoprotein and multidrug resistance-associated protein, but not lung resistance protein, lower the intracellular daunorubicin accumulation in acute myeloid leukaemic cells
Authors: Borg, AG Burgess, R Green, LM Scheper, RJ Yin, JAL
Citation: Ag. Borg et al., P-glycoprotein and multidrug resistance-associated protein, but not lung resistance protein, lower the intracellular daunorubicin accumulation in acute myeloid leukaemic cells, BR J HAEM, 108(1), 2000, pp. 48-54
Molecular quantitation of minimal residual disease in acute myeloid leukemia with t(8;21) can identify patients in durable remission and predict clinical relapse
Authors: Tobal, K Newton, J Macheta, M Chang, J Morgenstern, G Evans, PAS Morgan, G Lucas, GS Yin, JAL
Citation: K. Tobal et al., Molecular quantitation of minimal residual disease in acute myeloid leukemia with t(8;21) can identify patients in durable remission and predict clinical relapse, BLOOD, 95(3), 2000, pp. 815-819
Effect on cell kill of addition of multidrug resistance modifiers cyclosporin A and PSC 833 to cytotoxic agents in chronic lymphocytic leukaemia
Authors: Grey, MR Burgess, R Fisher, A Yin, JAL
Citation: Mr. Grey et al., Effect on cell kill of addition of multidrug resistance modifiers cyclosporin A and PSC 833 to cytotoxic agents in chronic lymphocytic leukaemia, LEUK RES, 23(1), 1999, pp. 29-35
Detection of minimal residual disease in acute myeloid leukaemia: Methodologies, clinical and biological significance
Authors: Yin, JAL Tobal, K
Citation: Jal. Yin et K. Tobal, Detection of minimal residual disease in acute myeloid leukaemia: Methodologies, clinical and biological significance, BR J HAEM, 106(3), 1999, pp. 578-590
The in vitro effect of pegylated recombinant human megakaryocyte growth and development factor (PEGrHuMGDF) on megakaryopoiesis in patients with aplastic anaemia
Authors: Brereton, ML Adams, JA Briggs, M Yin, JAL
Citation: Ml. Brereton et al., The in vitro effect of pegylated recombinant human megakaryocyte growth and development factor (PEGrHuMGDF) on megakaryopoiesis in patients with aplastic anaemia, BR J HAEM, 104(1), 1999, pp. 119-126
A randomized, double-blind, placebo-controlled study with pegylated recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF) as anadjunct to chemotherapy for adults with de novo acute myeloid leukemia
Authors: Archimbaud, E Ottmann, OG Yin, JAL Lechner, K Dombret, H Sanz, MA Heil, G Fenaux, P Brugger, W Barge, A O'Brien-Ewen, C Matcham, J Hoelzer, D
Citation: E. Archimbaud et al., A randomized, double-blind, placebo-controlled study with pegylated recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF) as anadjunct to chemotherapy for adults with de novo acute myeloid leukemia, BLOOD, 94(11), 1999, pp. 3694-3701
Untitled
Authors: Tobal, K Yin, JAL
Citation: K. Tobal et Jal. Yin, Untitled, LEUKEMIA, 12(12), 1998, pp. 1991-1991
Overexpression of lung-resistance protein and increased P-glycoprotein function in acute myeloid leukaemia cells predict a poor response to chemotherapy and reduced patient survival
Authors: Borg, AG Burgess, R Green, LM Scheper, RJ Yin, JAL
Citation: Ag. Borg et al., Overexpression of lung-resistance protein and increased P-glycoprotein function in acute myeloid leukaemia cells predict a poor response to chemotherapy and reduced patient survival, BR J HAEM, 103(4), 1998, pp. 1083-1091
Risultati: 1-17 |